Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
David M CognettiJennifer M JohnsonJoseph M CurrySamith T KochuparambilDarren McDonaldFrank MottMary J FidlerKerstin StensonNilesh R VasanMohammad A RazaqJohn CampanaPatrick HaGrace MannKosuke IshidaMiguel Garcia-GuzmanMerrill BielAnn M GillenwaterPublished in: Head & neck (2021)
NCT02422979.